No definition available.
Mucinous and mucinous cystic tumor, excluding all cancers (controls excluding all cancers)
C3_OVARY_MUCINO_EXALLC
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleonly females |
293373 |
2. Check conditionsNone |
293373 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
233 |
4. Check minimum number of eventsNone |
233 |
5. Include endpointsNone |
233 |
6. Filter based on genotype QC (FinnGen only) |
233 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE_EXALLC
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Mucinous and mucinous cystic tumor, excluding all cancers (controls excluding all cancers)
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)
- malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, wide definition for exclusion
- Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 233 | 233 | - |
| Unadjusted period prevalence (%) | 0.08 | 0.08 | - |
| Median age at first event (years) | 54.36 | 54.36 | - |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 142
- Matched controls
- 1420
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C56.72
ICD-10 Finland
Mucinous epithelial carcinoma of the ovary
+∞
155.0
119
*
8470/3-C56.9
ICD-O-3
Mucinous cystadenocarcinoma, NOS, of ovary
+∞
114.6
94
*
8480/3-C56.9
ICD-O-3
Mucinous adenocarcinoma of ovary
+∞
53.6
48
*
JAL30
NOMESCO Finland
Omentectomy
381.5
52.9
50
*
128
Kela drug reimbursment
Cancers of female genital organs
+∞
44.1
40
*
D39.10
ICD-10 Finland
Tumor of uncertain or unknown nature in the ovary without histology
54.1
42.7
50
14
LAF16
NOMESCO Finland
Excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer
+∞
39.4
36
*
JEA00
NOMESCO Finland
Appendectomy
25.0
35.5
51
31
LAF10
NOMESCO Finland
Bilateral salpingo-oophorectomy
30.2
32.1
43
20
LCD00
NOMESCO Finland
Hysterectomy
20.7
32.0
49
35
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
30.8
31.5
42
19
C56
ICD-10 Finland
Malignant neoplasm of ovary
+∞
24.7
23
*
H02AB02
ATC
dexamethasone; systemic
57.6
24.4
28
6
C56.00
ICD-10 Finland
Malignant tumor of the ovary without histology
+∞
22.5
21
*
A04AA01
ATC
ondansetron; systemic, rectal
19.9
19.3
29
18
WX302
NOMESCO Finland
Thoracal epidural anesthesy
21.9
18.7
27
15
121
Kela drug reimbursment
Severe hypofunction of sexual glands
22.4
18.1
26
14
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
18.1
17
*
C56.71
ICD-10 Finland
Serous epithelial malignant tumor of the ovary
+∞
18.1
17
*
LX1XE
NOMESCO Finland
Other gynecological ultrasound examination
14.3
17.6
30
26
JAL00
NOMESCO Finland
Biopsy of peritoneum
102.3
17.0
18
*
D39.11
ICD-10 Finland
Epithelial tumor of uncertain nature in the ovary
54.4
16.5
19
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
15.9
15
*
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
5.8
15.4
49
118
A03FA01
ATC
metoclopramide; systemic, rectal
5.9
15.3
48
113
LAF00
NOMESCO Finland
Unilateral salpingo-oophorectomy
20.3
14.3
21
12
A04AA02
ATC
granisetron; systemic, transdermal
+∞
13.8
13
*
L03AA13
ATC
pegfilgrastim; parenteral
+∞
13.8
13
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
+∞
13.8
13
*
B01AB10
ATC
tinzaparin; parenteral
10.2
13.5
27
32
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
4.0
13.5
84
380
JN4BD
NOMESCO Finland
Extensive body CT
11.0
13.1
25
27
B01AB05
ATC
enoxaparin; parenteral
3.9
12.4
68
271
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
12.1
11.7
21
20
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
11.6
11
*
Z31.5
ICD-10 Finland
Genetic counselling
10.2
11.3
22
25
1830A
ICD-9 Finland
Malignant neoplasm of ovary and other uterine adnexa, Ovary
+∞
10.5
10
*
C567
ICD-10 Finland
NA
+∞
10.5
10
*
130
Kela drug reimbursment
Malignant tumour
+∞
10.5
10
*
115
Kela drug reimbursment
Breast cancer
+∞
10.5
10
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
10.5
10
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
6.2
10.2
28
54
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
18.4
10.1
15
9
TLE20
NOMESCO Finland
Transvaginal puncture of cul-de-sac
59.1
9.8
11
*
L03AA02
ATC
filgrastim; parenteral
+∞
9.5
9
*
PJD44
NOMESCO Finland
Excision of iliac lymph nodes
+∞
9.5
9
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
9.5
9
*
C56.79
ICD-10 Finland
Other epithelial carcinoma of the ovary
+∞
9.5
9
*
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
4.1
8.8
37
113
JN4AD
NOMESCO Finland
Body CT examination
11.8
8.5
15
14
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
8.4
8
*
D39.19
ICD-10 Finland
Tumor of uncertain or unknown nature in the ovary with unspecified histology
35.6
8.2
10
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
14.4
7.5
12
9
A04AA03
ATC
tropisetron; systemic
+∞
7.3
7
*
X77
ICPC
Malignant neopl genital female other
+∞
7.3
7
*
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
+∞
7.3
7
*
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
+∞
7.3
7
*
L02BG04
ATC
letrozole; oral
31.8
7.2
9
*
D27.91
ICD-10 Finland
Benign epithelial tumor of the ovary (ovary)
10.9
7.2
13
13
R18
ICD-10 Finland
Ascites
42.1
6.8
8
*
TPH07
NOMESCO Finland
Cathetrisation of artery
5.2
6.7
20
43
JAH00
NOMESCO Finland
Laparotomy
19.1
6.3
9
5
C56.98
ICD-10 Finland
Malignant tumor of the ovary, indeterminate histology
+∞
6.3
6
*
18301
ICD-8 Finland
Malignant neoplasm of ovary, Fallopian tube and broad ligament, Ovary
+∞
6.3
6
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
6.3
6
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
6.3
6
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
6.3
6
*
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
3.4
6.2
31
109
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
79
96
11.94
64.46
2.8
1.4
13.1
2.7
ug/l
1.35
63
74
15
6
26.55
11.29
1.1
1.7
—
—
—
0
0
72
404
2.13
6.21
2.3
1.8
—
—
—
0
0
122
836
1.96
5.99
4.4
3.5
—
—
—
0
0
40
178
2.51
5.90
8.9
5.5
1.2
1.9
mmol/l
0.56
33
147
111
796
1.75
4.25
4.8
3.2
34.8
36.2
g/l
1.42
105
730
113
828
1.71
3.91
6.8
4.5
1.2
1.2
mmol/l
1.91
101
735
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
12
34
3.67
3.82
2.8
2.9
0.3
0.4
u/ml
—
6
21
47
269
1.94
3.69
1.6
1.7
—
—
—
0
0
174
1966
0.55
3.68
6.1
5.3
1.9
2.5
mu/l
0.45
157
1807
181
2016
0.54
3.46
4.1
4.6
5.9
5.9
mmol/l
0.35
156
1849
166
1893
0.57
3.46
5.3
5.8
39.6
39.5
mmol/mol
0.04
148
1760
35
186
2.04
3.38
1.5
1.7
—
—
—
0
0
35
187
2.03
3.33
1.5
1.7
—
—
—
0
0
120
923
1.62
3.25
7.5
4.9
1.2
1.2
mmol/l
3.26
102
794
188
2062
0.54
3.12
4.1
5.1
2.8
2.8
mmol/l
0.11
165
1901
20
88
2.39
3.03
14.3
5.2
25.4
25.8
mmol/l
0.16
20
88
27
136
2.11
3.00
11.4
4.3
1.2
1.3
mmol/l
0.28
27
131
20
91
2.31
2.83
12.3
6.4
0.5
0.7
%
1.05
20
91
129
1032
1.56
2.81
14.6
6.2
4.0
4.2
e9/l
0.46
105
891
20
92
2.28
2.76
11.9
6.4
1.2
1.4
%
0.67
20
92
8
20
4.10
2.59
1.1
1.3
—
—
—
0
0
40
244
1.77
2.56
2.6
1.6
28.9
29.3
s
0.16
40
237
6
11
5.57
2.56
1.2
1.2
—
—
—
0
0
185
2020
0.59
2.52
3.8
4.6
4.8
4.9
mmol/l
0.15
166
1869
7
16
4.48
2.49
1.1
1.3
—
—
—
0
0
6
13
4.71
2.28
1.2
1.4
—
—
—
0
0
200
2132
0.56
2.24
13.8
8.6
23.2
23.2
u/l
0.00
190
2046
131
1089
1.46
2.15
6.5
3.7
6.6
6.6
mmol/l
0.02
121
991
185
2007
0.62
2.15
3.7
4.5
1.6
1.6
mmol/l
0.85
163
1851
22
119
1.94
2.05
1.6
1.6
—
—
—
0
0
7
21
3.40
1.98
1.6
1.1
—
—
—
0
0
114
934
1.43
1.96
8.4
3.2
9.3
10.4
umol/l
1.66
108
869
8
183
0.42
1.91
2.0
1.9
—
—
—
0
0
33
492
0.62
1.81
1.2
1.3
0.6
2.3
u/ml
1.73
13
140
199
2111
0.61
1.81
23.1
12.9
68.8
69.7
umol/l
0.25
199
2111
40
273
1.56
1.69
3.6
2.7
2.7
4.0
e6/l
0.49
22
128
178
1927
0.68
1.68
3.4
4.1
1.3
1.2
mmol/l
0.92
152
1756
8
31
2.64
1.67
1.6
1.2
—
—
—
0
0
7
25
2.85
1.66
1.4
1.2
—
—
—
0
0
82
650
1.40
1.64
4.0
1.9
2.4
2.4
mmol/l
0.67
69
541
5
14
3.62
1.62
1.0
1.0
—
—
—
0
0
7
26
2.74
1.59
1.0
1.2
—
—
—
0
0
74
916
0.72
1.54
2.6
2.7
105.4
84.3
ug/l
0.66
64
846
25
381
0.61
1.50
1.6
1.6
—
—
—
0
0
74
912
0.72
1.49
2.0
2.4
75.9
79.7
nmol/l
0.51
61
813
42
299
1.49
1.47
3.2
2.5
1.0
1.2
e6/l
0.28
23
154
5
17
2.98
1.36
2.0
1.2
—
—
—
0
0
14
76
1.90
1.33
4.4
2.9
45.3
47.2
%
0.12
14
76
6
24
2.54
1.31
1.8
1.2
—
—
—
0
0
162
1466
1.34
1.27
8.7
5.1
78.6
75.9
u/l
0.48
148
1345
8
36
2.26
1.25
1.6
1.2
—
—
—
0
0
176
1886
0.73
1.24
18.4
10.3
82.1
79.3
ml/min/173m2
0.90
143
1509
8
37
2.20
1.22
1.1
1.2
—
—
—
0
0
8
37
2.20
1.22
1.1
1.2
—
—
—
0
0
110
1255
0.77
1.21
2.4
3.0
—
—
—
0
0
8
38
2.14
1.19
3.0
2.4
—
—
—
0
0
5
20
2.53
1.15
1.2
1.2
—
—
—
0
0
15
88
1.75
1.14
2.7
2.0
0.9
1.1
%
0.36
15
88
16
96
1.72
1.13
1.4
1.5
—
—
—
0
0
12
200
0.58
1.04
1.9
2.1
—
—
—
0
0
10
54
1.89
0.98
1.2
1.2
—
—
—
0
0
5
101
0.48
0.92
1.2
1.5
—
—
—
0
0
60
496
1.28
0.87
4.5
2.9
0.3
0.5
e6/l
0.63
47
365
141
1529
0.80
0.86
4.1
4.3
17.0
12.0
mm/h
2.13
130
1398
8
46
1.76
0.83
1.4
1.4
—
—
—
0
0
198
2058
0.75
0.79
21.8
13.4
3.9
3.9
mmol/l
0.66
192
1996
7
38
1.87
0.74
1.1
1.3
—
—
—
0
0
7
41
1.73
0.70
1.1
1.1
—
—
—
0
0
7
116
0.59
0.70
1.0
1.1
—
—
—
0
0
20
270
0.72
0.69
3.9
4.5
32.6
33.3
%
—
9
165
161
1705
0.82
0.68
5.2
4.4
15.2
14.7
pmol/l
1.90
147
1562
77
866
0.83
0.62
2.0
2.0
96.7
99.1
pmol/l
0.16
40
398
0
22
0.00
0.59
0.0
1.0
—
—
—
0
0
0
22
0.00
0.59
0.0
1.0
—
—
—
0
0
8
53
1.53
0.59
1.9
1.6
—
0.3
—
0
7
69
605
1.20
0.59
3.3
2.0
51.4
57.2
u/l
0.45
62
557
0
23
0.00
0.58
0.0
1.1
—
85.4
—
0
5
111
1016
1.18
0.58
4.8
3.8
0.0
0.0
estimate
0.50
22
181
73
646
1.19
0.56
4.3
2.9
—
—
—
0
0
68
599
1.19
0.55
4.8
2.4
29.1
28.3
u/l
0.11
63
572
191
1976
0.81
0.53
17.3
11.4
30.6
18.9
mg/l
4.31
165
1505
6
99
0.60
0.53
5.8
3.5
5.1
5.3
kpa
—
6
92
11
76
1.47
0.49
1.3
1.5
—
—
—
0
0
10
68
1.49
0.47
1.7
1.6
—
—
—
0
0
43
498
0.83
0.47
1.5
1.5
19.3
22.8
nmol/l
0.83
36
425
19
147
1.32
0.47
5.5
1.4
65.5
68.0
g/l
1.32
19
134
5
81
0.61
0.46
1.4
1.8
—
—
—
0
0
109
1010
1.15
0.46
7.2
5.2
0.0
0.0
estimate
0.00
20
174
6
93
0.64
0.43
5.7
3.3
2.5
2.0
mmol/l
—
6
70
50
439
1.18
0.42
2.1
1.7
1.4
0.9
mg/l
1.08
44
343
0
15
0.00
0.41
0.0
1.7
—
—
—
0
0
0
16
0.00
0.41
0.0
1.1
—
1.1
—
0
9
0
17
0.00
0.41
0.0
1.2
—
—
—
0
0
7
102
0.68
0.40
1.3
1.5
—
—
—
0
0
10
71
1.43
0.40
1.9
1.6
—
—
—
0
0
36
416
0.84
0.39
1.3
1.3
46.9
37.7
iu/ml
—
10
140
5
78
0.63
0.36
1.4
1.4
—
—
—
0
0
6
87
0.68
0.33
1.5
1.7
—
—
—
0
0
6
46
1.31
0.33
1.2
1.2
—
—
—
0
0
20
165
1.23
0.32
1.2
1.2
192.7
133.6
iu/ml
—
8
67
35
392
0.87
0.27
1.9
1.7
1115.9
1162.3
nmol/l
0.08
18
291
5
73
0.68
0.26
9.0
1.3
—
—
—
0
0
52
477
1.12
0.25
3.2
2.0
9775.5
5410.8
umol/l
0.18
47
401
10
126
0.78
0.25
1.9
1.4
—
—
—
0
0
161
1655
0.91
0.23
23.1
13.7
13.9
13.6
%
1.92
155
1620
12
97
1.25
0.23
1.3
1.7
—
—
—
0
0
18
153
1.19
0.23
2.9
1.8
57.7
67.4
ml/min/173m2
—
6
63
74
785
0.92
0.22
5.1
3.9
—
—
—
0
0
0
11
0.00
0.21
0.0
1.4
—
4.6
—
0
11
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
11
0.00
0.21
0.0
1.7
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
0
10
0.00
0.21
0.0
2.0
—
—
—
0
0
0
10
0.00
0.21
0.0
2.0
—
—
—
0
0
0
13
0.00
0.21
0.0
1.9
—
56.4
—
0
8
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
0
14
0.00
0.20
0.0
1.8
—
—
—
0
0
104
998
1.08
0.19
4.8
3.8
0.0
0.0
estimate
0.00
20
183
6
52
1.16
0.19
1.7
1.4
—
—
—
0
0
40
433
0.91
0.18
1.4
1.7
459.3
452.4
pmol/l
0.04
33
354
5
69
0.72
0.17
9.0
1.3
7.0
10.4
g/l
—
5
58
6
77
0.77
0.16
2.0
2.5
40.5
42.5
u/l
—
6
67
6
79
0.75
0.15
1.2
1.3
—
23.7
—
0
6
49
463
1.07
0.13
1.4
1.4
—
—
—
0
0
71
737
0.95
0.11
3.7
3.5
19.0
71.4
ng/l
0.53
49
479
55
526
1.06
0.11
3.3
2.8
1239.2
1072.7
ng/l
0.13
46
428
35
370
0.94
0.09
3.4
2.0
2.5
2.4
mmol/l
2.25
30
319
5
46
1.09
0.09
3.0
3.0
849.0
81.2
ug/min
—
5
33
26
245
1.07
0.07
7.0
6.1
—
—
—
0
0
8
90
0.88
0.07
1.0
1.4
—
—
—
0
0
39
405
0.96
0.06
1.2
1.3
3.7
11.8
u/ml
1.33
16
154
51
524
0.97
0.05
4.8
4.1
0.0
0.0
estimate
0.00
17
181
178
1792
0.97
0.03
20.3
12.8
37.9
39.5
%
1.27
117
1280
129
1280
1.02
0.02
3.4
2.8
43.6
37.5
u/l
0.44
116
1187
18
181
0.99
0.00
4.9
3.0
—
—
—
0
0
17
174
0.98
0.00
2.2
1.7
—
—
—
0
0
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
5
59
0.84
0.00
1.0
1.8
—
—
—
0
0
5
59
0.84
0.00
1.0
1.3
—
226.9
—
0
22
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
6
68
0.88
0.00
1.0
1.1
—
10.0
—
0
9
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
99.2
—
0
5
0
5
0.00
0.00
0.0
1.4
—
454.2
—
0
5
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
1.8
—
184.0
—
0
5
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: C3_OVARY_MUCINO_EXALLC – Mucinous and mucinous cystic tumor, excluding all cancers (controls excluding all cancers)
GWS hits: 1
This endpoint is excluded (different definition than used in FinnGen).